These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: In situ H2O2 generation with gold nanoflowers as the coreactant accelerator for enzyme-free electrochemiluminescent immunosensing. Author: Hu Q, Yang J, Zheng Z, Ding Y, Chen Y, Gao W. Journal: Biosens Bioelectron; 2019 Oct 15; 143():111627. PubMed ID: 31476601. Abstract: In traditional electrochemiluminescence (ECL) analysis, gold nanomaterials are commonly used as a tool for signal amplification and linking antibodies due to their good electrical conductivity and biocompatibility. Here, we found that multitipped gold nanoparticles-gold nanoflowers (AuNFs) as coreactant accelerator have good catalytic activity for the reduction of dissolved oxygen (O2) to hydrogen peroxide (H2O2) using tris (hydroxymethyl) aminomethane (Tris) as electron donor. Based on this, a new enzyme-free and label-free ECL immunosensor have been constructed for the detection of α-fetoprotein (AFP). In this system, due to the unique geometric and spatial effects of AuNFs, the dissolved O2 as endogenous coreactant was catalyzed by AuNFs to produce H2O2 using Tris as an electron donor. The in situ generated H2O2 can more efficiently produce various electrogenerated reactive oxygen species (ROSs) as the important intermediates on the electrode surface. Then, oxidation of luminol reacts with ROSs significantly amplifies the luminol ECL signal. Under optimal experimental conditions, the proposed ECL immunosensor was able to detect the AFP concentration from 0.01 to 100 ng mL-1, with a low detection limit of 3.4 pg mL-1 (S/N = 3). In addition, the prepared ITO-based sensor is similar to a micro-test chip and convenient to use, thus making it suitable for clinical use as a disposable device in point-of-care tests (POCTs).[Abstract] [Full Text] [Related] [New Search]